Fabino Life Sciences Limited IPO Detail
Fabino Life Sciences is engaged in the manufacturing, marketing, trading, and packing of pharmaceutical and other wellness-focused consumer products. The company's core business is the marketing of pharmaceutical formulation & products in the domestic market through their own distribution network and sales force under their brand name, getting ayurvedic formulations manufactured through loan licensing facilities, packing, labeling, etc. The company export wellness and FMCG products like coffee, malt powder, protein powder, hair shampoo marketed by them.
Currently, the company has over 70 launched and active products available in markets categorized into (i) Allopathic, (ii) Covid 19, (iii) Food & Wellness, (iv) Herbal, (v) Veterinary, (vi) Multi-Vitamin, segments. The shampoo and hair maintenance products from the company are under the brand - Keepshine, while all the others products are marketed under the brand - Fabino. The company has its manufacturing unit in the National Capital Region, India.
Competitive Strengths:
- An experienced promoter from the pharmaceutical industry
- Diverse product portfolio
- More than 70 registrations for trademarks of products
- Low debt balance sheet
- Strong marketing and distribution network
Company Promoters
Atul Kumar JainIPO Details
| IPO Opening Date | Dec 31, 2021 |
| IPO Closing Date | Jan 05, 2022 |
| Issue Type | Fixed Price Issue IPO |
| Face Value | ₹10 per equity share |
| IPO Price | ₹36 per equity share |
| Market Lot | 3000 Shares |
| Min Order Quantity | 3000 Shares |
| Listing At | BSE SME |
| Issue Size | ₹3.24 Cr |
| Fresh Issue | ₹3.24 Cr |
| Offer for Sale | - |
| Retail Portion | 50% |
IPO Subscription (Bidding Detail)
| AS On | QIB | SHNI | BHNI | NII | RII | TOTAL |
|---|---|---|---|---|---|---|
| Day 1 | - | - | 0.79x | 0.50x | 0.64x | |
| Day 2 | - | - | 1.69x | 3.61x | 2.65x | |
| Day 3 | - | - | 1.97x | 5.77x | 3.87x | |
| Day 4 | - | - | 3.49x | 10.36x | 6.93x |
IPO Tentative Timetable
The Fabino Life Sciences Limited IPO open date is Dec 31, 2021, and the close date is Jan 05, 2022. The issue may list on Jan 13, 2022.
| IPO Open Date | Dec 31, 2021 |
| IPO Close Date | Jan 05, 2022 |
| Basis of Allotment Date | Jan 10, 2022 |
| Initiation of Refunds | Jan 11, 2022 |
| Credit of Shares to Demat Account | Jan 12, 2022 |
| IPO Listing Date | Jan 13, 2022 |
IPO Lot Size
The Fabino Life Sciences Limited IPO market lot size is 3000 shares. A retail-individual investor can apply for up to 1 lots (3000 shares or ₹108000).
| Application | Lots | Shares | Amount (Cut-off) |
|---|---|---|---|
| Minimum | 1 | 3000 | ₹108000 |
| Maximum | 1 | 3000 | ₹108000 |
IPO Promoter Holding
| Pre Issue Share Holding | 99.43% |
| Post Issue Share Holding | 56.82% |
Company Financials:
For the year/period ended (₹ in Millions)
| Financial Year | Total Assets | Total Revenue | Profit After Tax |
|---|---|---|---|
| 30-Jun-21 | 28.14 | 11.29 | 0.14 |
| 31-Mar-21 | 22.51 | 30.59 | 0.30 |
| 31-Mar-20 | 35.88 | 75.16 | 0.68 |
| 31-Mar-19 | 85.53 | 27.61 | 0.001 |
Objects of the Issue:
- Part repayment of loans
- Funding working capital requirements
- General corporate purposes
Fabino Life Sciences Limited IPO Registrar:
Bigshare Services Pvt Ltd
Fabino Life Sciences Limited IPO Lead Manager(s):
Aryaman Financial Services limited
